These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39679312)

  • 1. Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease.
    Liu Chen Kiow J; Hoang T; Bedi HK; Majdzadeh Ardekani Z; Rosenfeld D; Reise-Filteau M; Bressler B; Leung Y; Rosenfeld G
    World J Gastroenterol; 2024 Dec; 30(46):4904-4913. PubMed ID: 39679312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
    Fischer S; Donhauser M; Cohnen S; Fietkau K; Vetter M; Grübel-Liehr M; Dietrich P; Rath T; Wilfer A; Sologub L; Krebs S; Dörje F; Nagore D; Meyer S; Neurath MF; Atreya R
    Therap Adv Gastroenterol; 2024; 17():17562848241301887. PubMed ID: 39619829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilar monoclonal antibodies for cancer treatment in adults.
    Galvao TF; Livinalli A; Lopes LC; Zimmermann IR; Silva MT
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD013539. PubMed ID: 39607013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China.
    Du X; Luo X; Guo Q; Jiang X; Su Z; Zhou W; Wang Z; Li J; Yang Y; Zhang Y
    Front Public Health; 2024; 12():1476213. PubMed ID: 39697288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study.
    Marras C; Labarga M; Ginard D; Carrascosa JM; Escudero-Contreras A; Collantes-Estevez E; de Mora F; Robles T; Romero E; Martínez R
    JMIR Form Res; 2024 Nov; 8():e56553. PubMed ID: 39622680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).
    Laharie D; Bouhnik Y; Vuitton L; Biron A; Pierron G; Brault Y; Assing M; Bouzidi A; Amiot A; Nancey S
    Clin Res Hepatol Gastroenterol; 2024 Dec; 48(10):102483. PubMed ID: 39448029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
    Fautrel B; Bouhnik Y; Salliot C; Carbonnel F; Fumery M; Bernardeau C; Maugars Y; Flamant M; Coury F; Braithwaite B; Hateb S; Addison J;
    Drugs Real World Outcomes; 2024 Dec; 11(4):573-591. PubMed ID: 39384685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
    Suárez Ferrer C; Mesonero Gismero F; Caballol B; Ballester MP; Bastón Rey I; Castaño García A; Miranda Bautista J; Saiz Chumillas R; Benitez JM; Sanchez-Delgado L; López-García A; Rubin de Celix C; Alonso Abreu I; Melcarne L; Plaza Santos R; Marques-Camí M; Caballero Mateos A; Gómez Díez C; Calafat M; Galan HA; Vega Vilaamil P; Castro Senosiain B; Guerro Moya A; Rodriguez Diaz CY; Spicakova K; Manceñido Marcos N; Molina G; de Castro Parga L; Rodriguez Angulo A; Cuevas Del Campo L; Rodriguez Grau MDC; Ramirez F; Gomez Pastrana B; Gonzalez Partida I; Botella Mateu B; Peña Gonzalez E; Iyo E; Elosua Gonzalez A; Sainz Arnau E; Hernandez Villalba L; Perez Galindo P; Torrealba Medina L; Monsalve Alonso S; Olmos Perez JA; Dueñas Sadornil C; Garcia Ramirez L; Martín-Arranz MD; López Sanroman A; Fernández A; Merino Murgui V; Calviño Suárez C; Flórez-Diez P; Lobato Matilla ME; Sicilia B; Soto Escribano P; Maroto Martin C; Mañosa M; Barreiro-De Acosta M;
    Gastroenterol Hepatol; 2024 Dec; 47(10):502197. PubMed ID: 38710465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Rubin DT; D'Haens G; Reinisch W; Watanabe M; Mehta R; Roblin X; Beales I; Gietka P; Hibi T; Hospodarskyy I; Ritter T; Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T; Danese S
    Lancet Gastroenterol Hepatol; 2024 Dec; ():. PubMed ID: 39637881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change from originator infliximab to biosimilar does not affect 1-year outcome in children with inflammatory bowel disease.
    Solomon V; Kuzoian S; Michel G; Brimacombe M; Hyams JS
    JPGN Rep; 2024 Nov; 5(4):442-446. PubMed ID: 39610440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.